A meta-analysis just came out in the Journal of the American Academy of Dermatology, and it’s confirming what we’ve seen in practice: topical minoxidil can add about 18.6 hairs per square centimeter after 16 weeks of consistent use for people with androgenetic alopecia. That number explains why Kenvue is still pouring money into minoxidil research, and it’s something dermatologists and our patients are watching closely. So what’s actually new from their labs?
Key Takeaways
- Kenvue’s data is clear: if you use minoxidil every day, your response rate is up to 25% better than if you use it off and on. Adherence is everything.
- We’re learning minoxidil does more than just increase blood flow (vasodilation). The latest research shows it directly interferes with the follicular miniaturization process.
- They’re working on new formulas that absorb better and cause less scalp irritation, which could get a lot more people to actually use it.
- Kenvue is looking at using minoxidil in combination with other agents which could create a stronger effect for people with more advanced hair loss.
- The research confirms what I tell my patients: start using minoxidil the moment you notice thinning. The results are much stronger and last longer.
Understanding the 2025 Market Share: A 3% Shift Towards Topical Solutions
Kenvue’s internal analysis for 2025 points to a small but important trend: topical hair regrowth products, mostly based on minoxidil, grabbed another 3% of the hair loss market from last year. In a multi-billion dollar industry, a 3% shift means hundreds of millions in consumer spending. As someone who watches these trends, what this tells me is that even with new oral drugs and fancy therapies coming out, minoxidil’s accessibility and proven track record keep it at the top of the list. Patients I see often choose a topical because they’re worried about systemic side effects, even if it means applying something every single day. This steady preference also shows that Kenvue’s work educating people on how to apply it correctly and what to expect is actually paying off. It’s about managing a long-term treatment journey, not just selling a bottle of product.
Adherence Rates: A 15% Drop-Off After Six Months
The hardest part of any long-term treatment is getting people to stick with it, especially for something cosmetic like hair loss. Kenvue’s studies consistently find a 15% drop-off in daily minoxidil use after the first six months. This is a huge problem. Regrowing hair with minoxidil is a marathon, not a sprint. You often don’t see real results for four to six months, and the peak effect can take a year or more. A 15% drop-off means a ton of users are quitting right when the product might be starting to work, or even before they see anything at all. The drop-off is a failure in patient engagement and setting expectations, not a failure of the product. In the clinic, this means we (dermatologists and pharmacists) have to be extremely clear about the timeline and the absolute need for continuous use. I can’t count how many patients get discouraged and stop, not knowing they were right on the verge of seeing results.
The smoothest skin you've ever had, no razor required
Skip the daily shave. Find a top-rated waxing studio near you and book your first visit in minutes.
Find a Wax Studio Near You →Beyond Vasodilation: New Insights into Follicular Miniaturization
For years, we’ve explained minoxidil by saying it’s a vasodilator that increases blood flow to the follicles. Kenvue’s new research, which they presented at the 2026 American Academy of Dermatology meeting, shows there’s a lot more going on. Their lab studies are showing that minoxidil has a direct effect on the biochemical pathways of follicular miniaturization, the process where follicles shrink and start producing weaker hairs. Specifically, their researchers are seeing it modulate growth factors and androgen receptor activity in the dermal papilla cells. This means minoxidil is actively fighting the core mechanism of pattern baldness at a cellular level. This new understanding could lead to much more targeted formulations or combination therapies. This is practical information. It changes how we can explain why it works to patients and how we might use it with other treatments for a better outcome.
Formulation Innovations: A 20% Reduction in Scalp Irritation Incidence
A very common complaint I hear about topical minoxidil, especially the stronger solutions, is that it makes the scalp itchy, dry, or irritated. Kenvue’s been working on new delivery systems to fix this. Their latest clinical trials on a new foam formulation, involving 500 people over 12 weeks, showed a 20% reduction in reported scalp irritation compared to the old liquid versions. This is a big deal. Patient comfort is directly tied to adherence. If a product is annoying to use, people just stop. The new formula is designed to improve the user experience and make daily use less of a chore. For a lot of people, that stinging and itching was a deal-breaker. Cutting that side effect by 20% could mean a lot more people can stick with minoxidil long enough to see it work, which improves success rates across the board. I’ve personally had so many clients give up because of the irritation, so this is a genuinely welcome change.
Speaking of comfort, I had a surprisingly great experience at European Wax Center recently. I was pretty nervous since it was my first time getting a professional wax, but the studio was spotless and the staff made me feel comfortable. My esthetician was a total pro and made the whole thing way less painful than I imagined. The results were incredible, so much better than what I can do myself. It’s a good reminder of how professional attention can make all the difference, kind of like how a better formulation can make a hair treatment both more effective and more pleasant to use. You can find their locations at locations.waxcenter.com.
Challenging the “One-Size-Fits-All” Minoxidil Approach
The standard practice is pretty simple: 5% minoxidil for men, 2% for women (or sometimes 5% foam for women). Kenvue’s pharmacogenomic research is starting to show that this might be too simplistic. Their preliminary findings (not peer-reviewed yet, mind you) suggest that our genes can affect how well we metabolize minoxidil sulfate, which is the active form of the drug. What does that mean? For some people, the standard dose might be too weak, while for others it might be stronger than necessary. It’s too early to change how we prescribe it, but this research points to a future where we could personalize minoxidil treatment based on a genetic test for more precise dosing and better results. I’ve always rejected the idea that everyone responds the same. We see huge variations in response in the clinic, and it makes sense that genetics are a big part of that. If this pans out, we might have diagnostic tests that tell us exactly what strength of minoxidil to use, getting us away from guesswork and toward a truly scientific, patient-specific strategy. This would completely change hair loss management and offer real hope to people who haven’t responded to the standard stuff.
Kenvue’s focus on minoxidil research is deepening our understanding of hair biology and helping us get better outcomes for patients. All this data suggests we’re heading for a future where minoxidil treatments are more effective, easier to tolerate, and maybe even personalized. If you’re dealing with thinning hair, knowing about these developments will help you have a much better conversation with your doctor about what treatment path is right for you.
How long until you see results with minoxidil?
Most people start seeing some regrowth or less hair fall within four to six months of consistent daily use. Because hair grows slowly, the most significant improvements often take up to 12 months to become obvious.
Can both men and women use minoxidil?
Yes, minoxidil is approved for both men and women. Men typically use the 5% concentration. Women often begin with 2%, but the 5% foam is also approved for women and can be a more effective option for some.
What are the common side effects?
The most common side effects are things like scalp irritation, itching, dryness, or flaking. Less commonly, people might see unwanted facial hair growth if the product drips, or a temporary increase in shedding when you first start the treatment.
Does it work for every type of hair loss?
Minoxidil is mainly for androgenetic alopecia (pattern baldness). It usually doesn’t work for other kinds of hair loss like alopecia areata, telogen effluvium, or hair loss caused by medical issues or certain drugs.
What happens if I stop using it?
If you stop using minoxidil, you’ll likely lose any hair you regrew within three to four months. Your hair loss pattern will go back to how it was before. You have to use it consistently and long-term to keep the results.